BCL2 and non-Hodgkin lymphoma: The results from RNA seq data analysis comparing the impact of genetic mutations of TP53, MYD88, MYC, BCL2, PIM1, and CREBBP show that metabolic genes included in nucleotide biosynthesis are upregulated in NHL tumors (Figure 7).